These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27799038)

  • 1. Polymer Nanoparticles as Smart Carriers for the Enhanced Release of Therapeutic Agents to the CNS.
    Gagliardi M; Borri C
    Curr Pharm Des; 2017; 23(3):393-410. PubMed ID: 27799038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
    Kanazawa T
    Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.
    Mulvihill JJ; Cunnane EM; Ross AM; Duskey JT; Tosi G; Grabrucker AM
    Nanomedicine (Lond); 2020 Jan; 15(2):205-214. PubMed ID: 31916480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric nanoparticles for drug delivery to the central nervous system.
    Patel T; Zhou J; Piepmeier JM; Saltzman WM
    Adv Drug Deliv Rev; 2012 May; 64(7):701-5. PubMed ID: 22210134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved brain uptake of peptide-based CNS drugs via alternative routes of administrations of its nanocarrier delivery systems: a promising strategy for CNS targeting delivery of peptides.
    Qian S; Wang Q; Zuo Z
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1491-508. PubMed ID: 25196358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnologies: a strategy to overcome blood-brain barrier.
    De Rosa G; Salzano G; Caraglia M; Abbruzzese A
    Curr Drug Metab; 2012 Jan; 13(1):61-9. PubMed ID: 22292810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting central nervous system pathologies with nanomedicines.
    Mizrahy S; Gutkin A; Decuzzi P; Peer D
    J Drug Target; 2019; 27(5-6):542-554. PubMed ID: 30296187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research advances in brain-targeted nanoscale drug delivery system].
    Liu Y; Jiang C
    Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of nano-therapeutics for major disorders of the central nervous system.
    Gao H; Pang Z; Jiang X
    Pharm Res; 2013 Oct; 30(10):2485-98. PubMed ID: 23797465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
    Crawford L; Rosch J; Putnam D
    J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of polymer architecture on curcumin encapsulation and release from PEGylated polymer nanoparticles: Toward a drug delivery nano-platform to the CNS.
    Rabanel JM; Faivre J; Paka GD; Ramassamy C; Hildgen P; Banquy X
    Eur J Pharm Biopharm; 2015 Oct; 96():409-20. PubMed ID: 26409200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS.
    Peluffo H; Unzueta U; Negro-Demontel ML; Xu Z; Váquez E; Ferrer-Miralles N; Villaverde A
    Biotechnol Adv; 2015; 33(2):277-87. PubMed ID: 25698504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery.
    Elzoghby AO; Abd-Elwakil MM; Abd-Elsalam K; Elsayed MT; Hashem Y; Mohamed O
    Curr Pharm Des; 2016; 22(22):3305-23. PubMed ID: 26845323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain drug delivery systems.
    Jiang X
    Pharm Res; 2013 Oct; 30(10):2427-8. PubMed ID: 23921487
    [No Abstract]   [Full Text] [Related]  

  • 17. Nano-enabled delivery systems across the blood-brain barrier.
    Hwang SR; Kim K
    Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembled amphiphilic core-shell nanocarriers in line with the modern strategies for brain delivery.
    Elezaby RS; Gad HA; Metwally AA; Geneidi AS; Awad GA
    J Control Release; 2017 Sep; 261():43-61. PubMed ID: 28648865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-Based Novel Lung Targeted Delivery Systems.
    Elmowafy E; Osman R; Ishak RA
    Curr Pharm Des; 2017; 23(3):373-392. PubMed ID: 27799039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
    Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
    Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.